Contentious Kratom Hearing Draws Users, Business Owners and Addiction Experts to Suffolk Legislature

A multi-hour public hearing on a proposed local law to restrict sale and distribution of kratom drew a broad cross-section of testimony on June 23. Consumers described symptom relief and improved daily functioning; small-business owners warned that tight restrictions or a ban would force kava bars and suppliers out of business.

Joanne Lynch, a Kings Park resident who said kratom eased her ulcerative-colitis spasms, told legislators, "To me, kratom was life-changing," and urged a regulatory path that preserves access for responsible adult users. Business owners urged standardized product labeling and regulated packaged servings, saying those steps would protect consumers and permit safe retail sales.

By contrast, Dr. Andrew Kolodny, an addiction-medicine specialist, told the Legislature that kratom contains opioid alkaloids and warned of public-health consequences. "Kratom contains opioids," he said, citing FDA analysis and a rise in kratom-involved hospitalizations and deaths. Dr. Kolodny recommended stricter local controls and pointed to recent peer-reviewed work linking kratom-involved deaths and emergency care to increased availability.

Owners of kava bars and distributors urged a narrower approach focused on labeling, testing and sale formats (pre-packaged, dosed beverages or tested capsules). Several business representatives described bank and health-department constraints and said industry-standard third-party lab testing is already common among reputable suppliers.

The hearing produced no immediate vote; legislators recessed the hearing for further review. Members said they will weigh medical, consumer and business evidence before deciding whether to advance a local ban, a targeted restriction on certain alkaloids or a registration-and-testing regime.